CoChat

Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy

Open access
Maziade, Pierre-Jean, Ship, Noam, Sniffen, Jason C, Goldstein, Ellie J C · 2021 · Clinical Infectious Diseases

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

When 70% of antibiotic users took a 3-strain Lactobacillus probiotic preparation the hospital-wide rate of healthcare-associated Clostridioides difficile infection improved significantly. The incidence of C. difficile infection for those taking the probiotic along with multiple antibiotics or a single high-risk antibiotic was decreased by at least half.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciab414

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Hospital-wide rate of primary healthcare-associated Clostridioides difficile (HA-CDI) cases (A) and recurrent CDI episodes (B) per 10 000 patient-days (pt-days) for each semiannual period. The semiannual periods refer to hospital data from the spring through summer [Periods 1-7] or from the autumn through winter [Periods 8-13]. Error bars for simple proportion represent 95% confidence intervals calculated with Fisher exact test. *P < .01 for hospital-wide rate of primary HA-CDI cases versus 1 year earlier; †P < .01 for hospital-wide rate of primary HA-CDI cases versus 1 and 2 years earlier; ‡P < .01 for hospital-wide rate of first recurrent HA-CDI cases versus 1 and 2 years earlier.
Figure 1. Hospital-wide rate of primary healthcare-associated Clostridioides difficile (HA-CDI) cases (A) and recurrent CDI episodes (B) per 10 000 patient-days (pt-days) for each semiannual period. The semiannual periods refer to hospital data from the spring through summer [Periods 1-7] or from the autumn through winter [Periods 8-13]. Error bars for simple proportion represent 95% confidence intervals calculated with Fisher exact test. *P < .01 for hospital-wide rate of primary HA-CDI cases versus 1 year earlier; †P < .01 for hospital-wide rate of primary HA-CDI cases versus 1 and 2 years earlier; ‡P < .01 for hospital-wide rate of first recurrent HA-CDI cases versus 1 and 2 years earlier.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 15

Metadata

Authors
Maziade, P.-J., Ship, N., Sniffen, J. C., & Goldstein, E. J. C.
Affiliations
  • Centre intégré de santé et de services sociaux de Lanaudière (CA)
  • Bio-K+ International (Canada) (CA)
  • AdventHealth Orlando (US)
  • R. M. Alden Research Laboratory, Santa Monica, California, USA
Corresponding author
Maziade, Pierre-Jean
Venue
Clinical Infectious Diseases
Published
2021-05-09
Volume
73
Issue
8
Pages
1524-1527
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W3162038454
Cited by
15
References
12
Citations by year
2026: 2 · 2025: 1 · 2023: 7 · 2022: 2 · 2021: 3
FWCI
0.95
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
Keywords
Clostridium difficile infection, probiotics, Lactobacillus, antibiotic-associated diarrhea, hospital pharmacy policy, nosocomial infection prevention
MeSH terms
Clostridioides, Anti-Bacterial Agents, Clostridium Infections, Diarrhea, Humans, Lactobacillus, Pharmacy, Clostridioides difficile, Probiotics, Policy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy. https://app.cochat.ai/papers/10.1093/cid/ciab414
The paper
Maziade, P.-J., Ship, N., Sniffen, J. C., & Goldstein, E. J. C. (2021). Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciab414

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.